Le Lézard
Classified in: Health
Subject: ATY

Kaskela Law LLC Announces Investigation of Xtant Medical Holdings, Inc. (XTNT) and Encourages XTNT Stockholders to Contact the Firm


PHILADELPHIA, Aug. 15, 2020 /PRNewswire/ -- Kaskela Law LLC announces that it is investigating Xtant Medical Holdings, Inc. ("Xtant") (NYSE: XTNT) on behalf of the company's stockholders. 

The investigation seeks to determine whether the members of Xtant's board of directors have violated the securities laws and/or breached their fiduciary duties, causing harm to the company and its stockholders.

Current Xtant stockholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (484) 258 ? 1585, or online at http://kaskelalaw.com/case/xtant/, to discuss this investigation and their legal rights and options.

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation.  For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.  This notice may constitute attorney advertising in certain jurisdictions.

CONTACT:

D. Seamus Kaskela, Esq.
KASKELA LAW LLC
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 258 ? 1585
(888) 715 ? 1740
[email protected] 
www.kaskelalaw.com

SOURCE Kaskela Law LLC


These press releases may also interest you

at 23:00
GenScript Singapore's Open Day Reveals Pioneering AI Capabilities in Recombinant Protein Production and Drug Discovery
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

at 23:00
Tech Innovator Purba Majumder Recognized as One of North America's Top 100 Women Leaders in 2024
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

at 22:33
Glycated Albumin Assay Market Projected to Reach $360.92 million by 2030 - Exclusive Report by 360iResearch
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

at 22:03
Health & Wellness Food Market Projected to Reach $859.43 billion by 2030 - Exclusive Report by 360iResearch
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

at 21:27
Hanmi Enters into Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BH3120 in Combination with KEYTRUDA® (pembrolizumab)
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...

at 19:30
Astellas' XTANDItm (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting
Astellas Pharma Inc....

More news about Health...


News published on and distributed by: